Jack A. Khattar Supernus Pharmaceuticals, Inc. (SUPN) insider trading activity

SUPN Quotes by TradingView

Jack A. Khattar is President, CEO of SUPERNUS PHARMACEUTICALS, INC.. Currently has a direct ownership of 926,172 shares of SUPN, which is worth approximately $29.8 Million. The most recent transaction as insider was on Aug 09, 2022, when has been sold 39,431 shares (Common Stock) at a price of $31.15 per share, resulting in proceeds of $1,228,276. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 926K
1.2% 3M change
6.77% 12M change
Total Value Held $29.8 Million

Jack A. Khattar Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 09 2022
SELL
Open market or private sale
$1,228,276 $31.15 p/Share
39,431 Reduced 5.16%
724,978 Common Stock
Aug 09 2022
BUY
Exercise of conversion of derivative security
-
63,100 Added 7.63%
764,409 Common Stock
Aug 08 2022
SELL
Open market or private sale
$3,744,726 $31.76 p/Share
117,907 Reduced 14.39%
701,309 Common Stock
Aug 08 2022
BUY
Exercise of conversion of derivative security
-
192,000 Added 18.99%
819,216 Common Stock
Mar 18 2022
BUY
Other acquisition or disposition
-
10,750 Added 1.69%
627,216 Common Stock
Mar 14 2022
BUY
Grant, award, or other acquisition
-
60,000 Added 8.87%
616,466 Common Stock
Jul 30 2021
BUY
Grant, award, or other acquisition
-
40,000 Added 6.71%
556,466 Common Stock
Mar 26 2021
BUY
Other acquisition or disposition
-
10,000 Added 1.9%
516,466 Common Stock

Also insider at

SCPH
scPharmaceuticals Inc. Healthcare
CGTX
COGNITION THERAPEUTICS INC Healthcare
Director
JAK

Jack A. Khattar

President, CEO
Rockville, MD

Track Institutional and Insider Activities on SUPN

Follow SUPERNUS PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SUPN shares.

Notify only if

Insider Trading

Get notified when an Supernus Pharmaceuticals, Inc. insider buys or sells SUPN shares.

Notify only if

News

Receive news related to SUPERNUS PHARMACEUTICALS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on SUPN